A formulation of MSD's cancer drug Keytruda that can be given by subcutaneous injection rather than intravenous infusion has cleared a phase 3 trial, setting up approvals later this year. The ...

The Golden State’s three investor-owned utilities will be required to pay at least $300 million combined annually into a fund starting in 2029. Edison International leaders call... Discover how ...